申聯生物(688098.SH):取得《獸藥GMP證書》和《獸藥生產許可證》
格隆匯11月20日丨申聯生物(688098.SH)公佈,蘭州分公司於近日通過了獸藥GMP驗收並取得甘肅省畜牧獸醫局核發的《獸藥GMP證書》和《獸藥生產許可證》。公司本次通過驗收的細胞懸浮培養病毒滅活疫苗(含細胞懸浮培養病毒亞單位疫苗)生產線可用於生產牛結節性皮膚病滅活疫苗、豬塞內卡病毒病滅活疫苗、豬偽狂犬病病毒基因缺失滅活疫苗及豬傳染性胃腸炎、豬流行性腹瀉、豬δ冠狀病毒病三聯滅活疫苗等產品。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.